American Scientists Win Nobel Prize in Medicine for Research on Human Sensory Receptors
(STOCKHOLM) — Two scientists won the Nobel Prize in medicine on Monday for their discoveries into how the human body perceives temperature and touch, revelations that could lead to new ways of treating pain or even heart disease. Americans David Julius and Ardem Patapoutian identified receptors in the skin that respond to heat and pressure. Their work is focused on the field of somatosensation, which explores the ability of specialized organs such as eyes, ears and skin to see, hear and feel. “This really unlocks one of the secrets of nature,” said Thomas Perlmann, secretary-general of the Nobel Committee...
Source: TIME: Health - October 4, 2021 Category: Consumer Health News Authors: AP / David Keyton and Frank Jordans Tags: Uncategorized medicine wire Source Type: news

Meet Ellacor, The New, Scar-Free Treatment That Improves Wrinkles And Loose Skin
Think that a facelift is the only way to target loose, aging? Think again.
Source: Forbes.com Healthcare News - August 24, 2021 Category: Pharmaceuticals Authors: Neera Nathan, MD , Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare Source Type: news

C is for Vitamin C -- a key ingredient for immune cell function
(La Jolla Institute for Immunology) Regulatory T cells (Tregs) help control inflammation and autoimmunity in the body. Unfortunately, it has proven difficult to find the right molecular ingredients to induce stable iTregs. Now a new study reports that Vitamin C and TET proteins can work together to give Tregs their life-saving power.
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Preparing T cells for the long haul
(La Jolla Institute for Immunology) In a new Nature Immunology study, researchers at La Jolla Institute for Immunology (LJI) report that T cells can be engineered to clear tumors without succumbing to T cell exhaustion.
Source: EurekAlert! - Cancer - July 19, 2021 Category: Cancer & Oncology Source Type: news

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants. Their new study, published online on July 1, 2021 in Cell Reports Medicine, shows that both CD4+ "helper" T cells and CD8+ "killer" T cells can still recognize mutated forms of the virus.
Source: World Pharma News - July 1, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Did your plastic surgeon really turn back the clock? Artificial intelligence may be able to quantify how young you actually look after facelift surgery
(Wolters Kluwer Health) For most patients, the reasons for having a facelift are simple: to " turn back the clock " for a younger and more attractive appearance. Even during the pandemic year 2020, more than 234,000 patients underwent facelift surgery, according to American Society of Plastic Surgeons (ASPS) statistics.
Source: EurekAlert! - Medicine and Health - June 30, 2021 Category: International Medicine & Public Health Source Type: news

Hard-working enzyme keeps immune cells in line
(La Jolla Institute for Immunology) Researchers at La Jolla Institute for Immunology (LJI) have shed light on a process in immune cells that may explain why some people develop cardiovascular diseases.
Source: EurekAlert! - Cancer - June 25, 2021 Category: Cancer & Oncology Source Type: news

Many cancer patients may need a sequential one-two punch of immunotherapies
(La Jolla Institute for Immunology) New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool may explain why many cancer patients do not respond to anti-PD-1 cancer immunotherapies--also called checkpoint inhibitors.The team reports that these patients may have tumors with high numbers of T follicular regulatory (Tfr) cells.
Source: EurekAlert! - Cancer - June 24, 2021 Category: Cancer & Oncology Source Type: news

How to watch the 2021 US Open: Tee times, channel, streaming and odds
Phil Mickelson is all the rave heading into the 2021 US Open at Torrey Pines Golf Course in La Jolla, California.
Source: Reuters: Health - June 17, 2021 Category: Consumer Health News Source Type: news

La Jolla Institute for Immunology launches new global cancer immunology resource
(La Jolla Institute for Immunology) The National Cancer Institute (NCI) of the National Institutes of Health has granted over $4.2 million to launch the Cancer Epitope Database and Analysis Resource (CEDAR), led by La Jolla Institute for Immunology (LJI) Professors Alessandro Sette, Dr. Biol. Sci., and Bjoern Peters, Ph.D.
Source: EurekAlert! - Medicine and Health - June 2, 2021 Category: International Medicine & Public Health Source Type: news

Antibody from cold can neutralize COVID-19 and could lead to vaccine against all coronaviruses
A new study from the Scripps Research Institute, in La Jolla, California, found higher levels of antibodies generated during the common cold in COVID survivors than in those never infected.
Source: the Mail online | Health - May 31, 2021 Category: Consumer Health News Source Type: news

LJI and Synbal, Inc. partner to develop better COVID-19 models
(La Jolla Institute for Immunology) The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news

A COVID-fighter's guide to T cells
(La Jolla Institute for Immunology) In a new paper, scientists from La Jolla Institute for Immunology (LJI) bring together research findings from COVID-19 researchers around the world. The results are striking: human T cells can target more than 1,400 sites on the SARS-CoV-2 virus.
Source: EurekAlert! - Biology - May 25, 2021 Category: Biology Source Type: news

Tanzania: Tanesco Donates Medical Tools to Bombo Hospital
[Daily News] TANZANIA Electricity Supply Company (Tanesco) has donated 4m/- worth of Medical equipment to Bombo Regional Hospital. The support, which is part of the state-owned corporation's social corporate responsibility, will be channeled towards the facelift of the medical facility's Paediatric unit.
Source: AllAfrica News: Health and Medicine - April 26, 2021 Category: African Health Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20